Dario N. R. Carrara
Directeur Général chez Amzell Ltd.
Provenance du réseau au premier degré de Dario N. R. Carrara
Entité | Type d'entité | Industrie | |
---|---|---|---|
Subsidiary | Pharmaceuticals: Major | 18 | |
Amzell Ltd.
Amzell Ltd. Pharmaceuticals: MajorHealth Technology Amzell Ltd. is a Dutch virtual development pharmaceutical company that specializes in taking candidate or repurposed drugs and devices through to proof of concept or registration for sale to commercial healthcare companies. The private company is based in Hoofddorp, Netherlands, and has subsidiaries in Switzerland. The company focuses on developing well-characterized active substances using innovative platform drug delivery technologies to provide more effective drug delivery, increased efficacy, and improved safety and compliance. One of their products, AMZ001, is a non-invasive topical gel formulation containing 3.06%% diclofenac sodium, which is a nonsteroidal anti-inflammatory drug (NSAID) used for the treatment of pain related to knee osteoarthritis. The CEO of the company is Dario N. R. Carrara.
2
| Private Company | Pharmaceuticals: Major | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Dario N. R. Carrara via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Sales & Marketing | |
E-Z-EM, Inc.
E-Z-EM, Inc. Medical SpecialtiesHealth Technology E-Z-EM, Inc. develops, manufactures and markets diagnostic imaging products. The firm's products are used for computed tomography and magnetic resonance imaging, colorectal cancer screening, evaluation of swallowing disorders and testing for other diseases, and disorders of the gastrointestinal system. The company was founded in 1961 and is headquartered in Lake Success, NY. | Medical Specialties | Corporate Officer/Principal | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
GT BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Union Carbide Corp.
Union Carbide Corp. Chemicals: Major DiversifiedProcess Industries Union Carbide Corp. engages in the production of chemicals and polymers. The firm operates through the following geographical segments: United States, Asia Pacific and Rest of the World. Its products include polyethylene and polypropylene, ethylene glycol, isopropanol, ethyleneamines, biocides, surfactants, deicing and anti-icing fluids, amines, solution vinyl resins and polyethylene glycols. The company was founded on November 1, 1917 and is headquartered in Seadrift, TX. | Chemicals: Major Diversified | Corporate Officer/Principal | |
InKine Pharmaceutical Co., Inc.
InKine Pharmaceutical Co., Inc. Pharmaceuticals: MajorHealth Technology Inkine Pharmaceutical Co., Inc. develops pharmaceutical products. The firm's products include Visicol(R) and IBStat(R). Its products are used for diagnosis and treatment of gastrointestinal disorders. The company was founded by Leonard S. Jacob in 1970 and is headquartered in Blue Bell, PA. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
PALATIN TECHNOLOGIES, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
SPECTRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
INTERPACE BIOSCIENCES, INC. | Medical Specialties | Chief Executive Officer | |
SICOR, Inc.
SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | Pharmaceuticals: Major | Director of Finance/CFO | |
ORASURE TECHNOLOGIES, INC. | Medical Specialties | Director/Board Member | |
DELCATH SYSTEMS, INC. | Medical Specialties | Chief Executive Officer | |
Permatec Holding AG
Permatec Holding AG Medical SpecialtiesHealth Technology Part of Halozyme Therapeutics, Inc., Permatec Holding AG develops novel transdermal and buccal drug delivery systems. The company is based in Allschwil, Switzerland. The Swiss company was founded by Jacques Gonella. Permatec Holding was acquired by Antares Pharma, Inc., part of Halozyme Therapeutics, Inc. from May 25, 2022 on February 01, 2000. | Medical Specialties | Founder | |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
PAXMEDICA, INC. | Biotechnology | Director/Board Member Director/Board Member | |
The Medical Device Manufacturers Association
The Medical Device Manufacturers Association Miscellaneous Commercial ServicesCommercial Services The Medical Device Manufacturers Association operates as a trade association. The private company is based in Washington. The American company was founded by Thomas C. Thompson. | Miscellaneous Commercial Services | Chairman | |
Cook, Inc.
Cook, Inc. Medical DistributorsDistribution Services Cook, Inc. develops healthcare devices. The company integrates minimally invasive medical device design, biopharma, gene and cell therapy, and biotech to enhance patient safety as well as improve clinical outcomes in the fields of aortic intervention, interventional cardiology, critical care medicine, gastroenterology, radiology, peripheral vascular, bone access & oncology, surgery and soft tissue repair, urology, and assisted reproductive technology, gynecology as well as high-risk obstetrics. The company is located in Bloomington, IN. | Medical Distributors | Corporate Officer/Principal | |
ImmunSYS, Inc.
ImmunSYS, Inc. Pharmaceuticals: MajorHealth Technology ImmunSYS, Inc. is a clinical stage biopharmaceutical company focused on the development of cancer immunotherapy products. The company was founded by Eamonn P. Hobbs and Charles J. Link Jr. in March 2018 and is headquartered in Fort Lauderdale, FL. | Pharmaceuticals: Major | Founder | |
Hobbs Medical Ventures, LLC
Hobbs Medical Ventures, LLC Miscellaneous Commercial ServicesCommercial Services Hobbs Medical Ventures, LLC provides consulting services for the pharmaceutical industry. The private company is based in New York, NY. The company was founded by Eamonn P. Hobbs. | Miscellaneous Commercial Services | Founder | |
Digital Cognition Technologies, Inc.
Digital Cognition Technologies, Inc. Medical SpecialtiesHealth Technology Digital Cognition Technologies, Inc. develops detect presymptomatic cognitive impairment and aid in tracking cognitive devices. The company was founded by Randall S. Davis, Dana L. Penney and Phil A. Cooper in 2015 and is headquartered in Waltham, MA. | Medical Specialties | Chief Executive Officer | |
Glens Falls Hospital, Inc.
Glens Falls Hospital, Inc. Hospital/Nursing ManagementHealth Services Glens Falls Hospital, Inc. provides health care services. It offers hospital, surgical and community services, and outpatient care centers. The company was founded in 1897 and is headquartered in Glens Falls, NY. | Hospital/Nursing Management | Director/Board Member | |
Namico, Inc. | Sales & Marketing | ||
SIR Foundation | Director/Board Member | ||
Sentinelle Medical ULC
Sentinelle Medical ULC Packaged SoftwareTechnology Services Sentinelle technology is developed by clinicians for clinicians and has evolved over ten years and more than 10000 patient trials. Its products come out of diagnostic imaging research initially conducted at Sunnybrook Health Sciences Centre and the University of Toronto Medical Biophysics department, and continuing over the past three years at Sentinelle. Its ongoing collaboration with academic institutions ensures Sentinelle technology is at the leading edge of the field of breast MRI imaging advances. Sentinelle develops products for General Electric Healthcare, Siemens Medical Solutions and Toshiba Medical Systems. Sentinelle Medical Inc., established in 2004, is a private company based in Toronto, Canada. | Packaged Software | Director/Board Member | |
Society of Interventional Radiology
Society of Interventional Radiology Miscellaneous Commercial ServicesCommercial Services The Society of Interventional Radiology is a national organization based in Fairfax, VA, consisting of physicians, scientists, and allied health professionals. The company is dedicated to improving public health through disease management and minimally invasive, image-guided therapeutic interventions. | Miscellaneous Commercial Services | Director/Board Member | |
Esocap AG
Esocap AG Pharmaceuticals: MajorHealth Technology Esocap AG is a privately funded company based in Basel, Switzerland. The Swiss company's vision is to improve the lives of patients with serious diseases of the upper gastrointestinal tract through the development of a unique and innovative topical drug delivery platform. The company is cooperating with key R&D and industrial partners, including the University of Greifswald, where the Esocap technology was invented by Prof. Werner Weitschies and his team. Esocap has filed several worldwide patents for their technology, which includes a capsule holder and production methods. The CEO of the company is Isabelle Racamier. | Pharmaceuticals: Major | Director/Board Member | |
AVANT DIAGNOSTICS INC | Medical Specialties | Director/Board Member | |
SkyePharma AG | Chief Executive Officer | ||
École Polytechnique Fédérale de Lausanne | College/University | Doctorate Degree | |
APR Applied Pharma Research SA
APR Applied Pharma Research SA BiotechnologyHealth Technology APR Applied Pharma Research SA develops and licenses healthcare products and technologies. It specializes in the development of oral and topical formulations in various healthcare regulatory areas ranging from Rx and OTC pharmaceuticals, nutraceuticals, dermocosmetics, and medical devices. The company was founded in 1990 and is headquartered in Balerna, Switzerland. | Biotechnology | Director/Board Member | |
ANGIODYNAMICS, INC. | Medical Specialties | Founder | |
University of Massachusetts | College/University | Undergraduate Degree | |
North American Instrument Corp. | Miscellaneous | Sales & Marketing | |
Hobbs Medical, Inc. | Founder | ||
Syncromune, Inc.
Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020. | Pharmaceuticals: Major | Chief Executive Officer | |
ACTINIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
University of Cincinnati (Ohio) | College/University | Masters Business Admin | |
University of Bath | College/University | Undergraduate Degree | |
University of Kansas | College/University | Doctorate Degree | |
Insmed Ltd.
Insmed Ltd. Pharmaceuticals: MajorHealth Technology Insmed Ltd. develops and manufactures pharmaceutical products for the treatment of lung diseases. Its products are used for the site-specific treatment of serious lung diseases such as pulmonary infections in cystic fibrosis patients and cancers affecting the lung. The company is located in London, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistiques
Internationale
Etats-Unis | 35 |
Suisse | 6 |
Royaume-Uni | 4 |
Nouvelle-Zélande | 2 |
Irlande | 2 |
Sectorielle
Health Technology | 27 |
Consumer Services | 6 |
Commercial Services | 5 |
Health Services | 3 |
Process Industries | 2 |
Opérationnelle
Director/Board Member | 77 |
Corporate Officer/Principal | 35 |
Chief Executive Officer | 23 |
President | 23 |
Independent Dir/Board Member | 23 |
Relations les plus connectées
Insiders | |
---|---|
Paul Wotton | 27 |
Eamonn Hobbs | 23 |
Jack Stover | 19 |
Anton G. Gueth | 16 |
Rajesh Shrotriya | 16 |
Leonard S. Jacob | 12 |
James Hattersley | 8 |
Robert F. Apple | 8 |
Jacques Gonella | 7 |
Roger G. Harrison | 7 |
Kaushik J. Dave | 7 |
Thomas J. Garrity | 6 |
Pavan Handa | 6 |
Patrick Madsen | 3 |
John Hayes | 3 |
- Bourse
- Insiders
- Dario N. R. Carrara
- Connexions Sociétés